2m 2m 2m 2m 2m 2m 2m
CONTINEUM THE-A (CTNM)
NASDAQ
$12.47+$0.09 (+0.73%)
Price as of Jun 03, 2026 4:04 PM EDT- $441.4MMarket Cap
- 161.18%1-Year Change
- BiotechnologyIndustry
CONTINEUM THE-A (CTNM)
$12.47+$0.09 (+0.73%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
SUVRETTA CAPITAL MANAGEMENT, LLC | 7.60% | 2.8M | 0 (0.00%) | Mar 31, 2026 |
JANUS HENDERSON GROUP PLC | 7.32% | 2.7M | +285,857 (+10.45%) | Mar 31, 2026 |
JOHNSON & JOHNSON | 5.29% | 2.0M | 0 (0.00%) | Mar 31, 2026 |
FRANKLIN RESOURCES INC | 4.92% | 1.8M | -40,140 (-2.18%) | Mar 31, 2026 |
BALYASNY ASSET MANAGEMENT L.P. | 4.51% | 1.7M | -157,165 (-9.32%) | Mar 31, 2026 |
MILLENNIUM MANAGEMENT LLC | 4.11% | 1.5M | +704,762 (+45.90%) | Mar 31, 2026 |
BAKER BROS. ADVISORS LP | 3.80% | 1.4M | 0 (0.00%) | Mar 31, 2026 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
VANGUARD INDEX FUNDS | 3.17% | 1.2M | +68,657 (+5.80%) | Mar 31, 2026 |
FRANKLIN STRATEGIC SERIES | 1.81% | 676,121 | +93,842 (+13.88%) | Jan 31, 2026 |
FIDELITY SELECT PORTFOLIOS | 1.20% | 450,000 | 0 (0.00%) | Feb 28, 2026 |
FIDELITY ADVISOR SERIES VII | 0.75% | 280,000 | 0 (0.00%) | Jan 31, 2026 |
iSHARES TRUST | 0.70% | 262,032 | +83,986 (+32.05%) | Mar 31, 2026 |
FIDELITY CONCORD STREET TRUST | 0.47% | 175,935 | +4,129 (+2.35%) | Feb 28, 2026 |
FIDELITY SALEM STREET TRUST | 0.29% | 108,958 | 0 (0.00%) | Mar 31, 2026 |
Current Ownership Distribution
- Institutions121.2M (86.69%)
- Mutual Funds15.9M (11.34%)
- Insiders2.8M (1.97%)
- Other0 (0.00%)
Insider Transactions
- 1.97% (2.8M)Current InsiderOwnership (%, shares)
- 0Number of InsiderBuying (last 12 months)
- $0.00Amount of InsiderBuying (last 12 months)
- 3Number of InsiderSelling (last 12 months)
- $23.1MAmount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Lorrain Daniel S. Chief Scientific Officer | Sell | Jun 01, 2026 | $54,862.19 | 4,170 | $13.16 | 139,372 |
Lorrain Daniel S. Chief Scientific Officer | Sell | May 01, 2026 | $50,542.20 | 3,870 | $13.06 | 143,842 |
Lorrain Daniel S. Chief Scientific Officer | Sell | May 01, 2026 | $4,152.00 | 300 | $13.84 | 143,542 |
Lorrain Daniel S. Chief Scientific Officer | Sell | Mar 02, 2026 | $62,585.03 | 4,170 | $15.01 | 151,882 |
Lorrain Daniel S. Chief Scientific Officer | Exempt | Feb 19, 2026 | $0.00 | 100 | $0.00 | 75,430 |
Lorrain Daniel S. Chief Scientific Officer | Exempt | Feb 19, 2026 | $101.00 | 100 | $1.01 | 156,152 |
Lorrain Daniel S. Chief Scientific Officer | Sell | Feb 19, 2026 | $1,600.00 | 100 | $16.00 | 156,052 |
Stengone Carmine N. CEO and President | Exempt | Feb 11, 2026 | $0.00 | 400 | $0.00 | 128,017 |
Lorrain Daniel S. Chief Scientific Officer | Exempt | Feb 11, 2026 | $0.00 | 400 | $0.00 | 75,530 |
Stengone Carmine N. CEO and President | Exempt | Feb 11, 2026 | $504.00 | 400 | $1.26 | 15,354 |
Lorrain Daniel S. Chief Scientific Officer | Exempt | Feb 11, 2026 | $404.00 | 400 | $1.01 | 156,452 |
Stengone Carmine N. CEO and President | Sell | Feb 11, 2026 | $6,400.00 | 400 | $16.00 | 14,954 |
Lorrain Daniel S. Chief Scientific Officer | Sell | Feb 11, 2026 | $6,400.00 | 400 | $16.00 | 156,052 |
Lorrain Daniel S. Chief Scientific Officer | Sell | Feb 03, 2026 | $44,468.70 | 3,000 | $14.82 | 157,222 |
Lorrain Daniel S. Chief Scientific Officer | Sell | Feb 03, 2026 | $17,836.77 | 1,170 | $15.25 | 156,052 |
Watkins Tim CMO & Head of Development | Award | Jan 30, 2026 | $0.00 | 160,000 | $0.00 | 160,000 |
Lorrain Daniel S. Chief Scientific Officer | Award | Jan 30, 2026 | $0.00 | 160,000 | $0.00 | 160,000 |
Slover Peter T Chief Financial Officer | Award | Jan 30, 2026 | $0.00 | 192,000 | $0.00 | 192,000 |
Lorrain Daniel S. Chief Scientific Officer | Award | Jan 30, 2026 | $0.00 | 6,500 | $0.00 | 6,500 |
Watkins Tim CMO & Head of Development | Exempt | Jan 28, 2026 | $16,249.50 | 3,611 | $4.50 | 3,611 |
Watkins Tim CMO & Head of Development | Sell | Jan 28, 2026 | $39,441.08 | 2,800 | $14.09 | 811 |
Watkins Tim CMO & Head of Development | Sell | Jan 28, 2026 | $11,747.17 | 811 | $14.48 | 0 |
Watkins Tim CMO & Head of Development | Exempt | Jan 28, 2026 | $0.00 | 3,611 | $0.00 | 252,778 |
Lorrain Daniel S. Chief Scientific Officer | Sell | Jan 05, 2026 | $37,978.26 | 3,670 | $10.35 | 160,722 |
Lorrain Daniel S. Chief Scientific Officer | Sell | Jan 05, 2026 | $5,564.90 | 500 | $11.13 | 160,222 |
Watkins Tim CMO & Head of Development | Exempt | Dec 29, 2025 | $0.00 | 3,611 | $0.00 | 256,389 |
Watkins Tim CMO & Head of Development | Exempt | Dec 29, 2025 | $16,249.50 | 3,611 | $4.50 | 3,611 |
Watkins Tim CMO & Head of Development | Sell | Dec 29, 2025 | $43,558.41 | 3,611 | $12.06 | 0 |
Lorrain Daniel S. Chief Scientific Officer | Sell | Dec 23, 2025 | $51,009.11 | 4,170 | $12.23 | 164,392 |
Lyons-Williams Lori | Award | Jun 26, 2025 | $0.00 | 14,750 | $0.00 | 14,750 |